MGNX News and Press, MacroGenics Inc. From 01/23/24

2024-01-23 13:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

MacroGenics, Inc. (NASDAQ: MGNX) is the focus of IBN's latest stock spotlight. The company's shares have moved 3.93% on the day to $5.16. MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved p...

2024-01-17 17:06:02 ET Gainers: Hertz Global Holdings ( HTZ ) +6% . GrabTaxi Holdings ( GRAB ) +4% . R1 RCM ( RCM ) +4% . Arhaus ( ARHS ) +3% . MacroGenics ( MGNX ) +2% . Losers: Adagene ( ADAG ) -8% . biote (...

2023-12-30 10:05:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-12-20 13:36:34 ET More on MacroGenics MacroGenics: This Top-Rated Stock Soars Big, But I'm Not Buying MacroGenics, Inc. (MGNX) Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on MacroGenics Historical earnings data for MacroGenics ...

2023-12-20 06:45:02 ET Guggenheim analyst issues BUY recommendation for MGNX on December 20, 2023 07:00AM ET. The previous analyst recommendation was Buy. MGNX was trading at $9.23 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current a...

2023-12-17 12:03:57 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips With so many innovative firms skyrocketing this year, astute investors seeking compelling discounts may want to turn their attention to undervalued biotech picks. Just like advancements in the ...

2023-12-08 07:30:59 ET Summary MacroGenics is a biopharmaceutical company focused on developing antibody-based treatments for cancer and autoimmune diseases. The company reported a decline in revenue but saw significant growth in earnings per share due to reduced expenses and a mi...

2023-11-29 17:30:44 ET Gainers: Nutanix ( NTNX ) +5% . Titan Machinery ( TITN ) +4% . Biomea Fusion ( BMEA ) +4% . Intuitive Machines ( LUNR ) +4% . Ocular Therapeutix ( OCUL ) +4% . Losers: Credo Technology Group  (...

2023-11-28 11:56:40 ET More on SPDR S&P 500 ETF Trust: 2024 Analyst Outlook: Mott Capital On Market Volatility, The Fed, And Investor Challenges And Opportunities The Week On Wall Street: Holiday Edition Broad Turn In Weekly Momentum Bodes Well For Stocks ...